Scientific Literature Search

Source record

Voice and choral singing treatment: a new approach for speech and voice disorders in Parkinson's disease.

Di Benedetto P, Cavazzon M, Mondolo F, Rugiu G, Peratoner A, Biasutti E.

Eur J Phys Rehabil Med · 2009-03-01

PMID: 18987565

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Electroconvulsive therapy in neuroacanthocytosis or McLeod syndrome.

Vázquez MJ, Martínez MC.

J ECT · 2009-03-01

DOI: 10.1097/yct.0b013e31817b06e0PMID: 18997633

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.

Hauser RA, Panisset M, Abbruzzese G, Mancione L, Dronamraju N, Kakarieka A, FIRST-STEP Study Group.

Mov Disord · 2009-03-01

DOI: 10.1002/mds.22343PMID: 19058133

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.

Hauser RA, Lew MF, Hurtig HI, Ondo WG, Wojcieszek J, Fitzer-Attas CJ, TEMPO Open-label Study Group.

Mov Disord · 2009-03-01

DOI: 10.1002/mds.22402PMID: 19086083

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.

Silverman RB.

Acc Chem Res · 2009-03-01

DOI: 10.1021/ar800201vPMID: 19154146

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Levodopa use and sleep in patients with dementia with Lewy bodies.

Molloy S, Minett T, O'Brien JT, McKeith IG, Burn DJ.

Mov Disord · 2009-03-01

DOI: 10.1002/mds.22411PMID: 19191343

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Deep brain stimulation versus best medical therapy for advanced Parkinson's disease.

Hariz M.

Lancet Neurol · 2009-03-01

DOI: 10.1016/s1474-4422(09)70027-4PMID: 19233027

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease.

Cuadrado A, Cuadrado A, Moreno-Murciano P, Pedraza-Chaverri J.

Expert Opin Ther Targets · 2009-03-01

DOI: 10.1517/13543780802716501PMID: 19236154

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Rotigotine transdermal delivery for the treatment of Parkinson's disease.

Rascol O, Perez-Lloret S.

Expert Opin Pharmacother · 2009-03-01

DOI: 10.1517/14656560902746041PMID: 19239399

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

[Treatment of degenerative dementia disorders--who should be treated?].

Hasselbalch SG, Kampmann JP.

Ugeskr Laeger · 2009-03-01

PMID: 19265606

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Pharmacotherapy guidelines for the aged by family doctors for the use of family doctors: part C--Special pharmacology.

Bergert FW, Conrad D, Ehrenthal K, Fessler J, Gross J, Gundermann K, Kluthe B, Lang Heinrich W, Liesenfeld A, Loew PG, Luther E, Pchalek R, Seffrin J, Sterzing A, Wolfring HJ, Zimmermann U.

Int J Clin Pharmacol Ther · 2009-03-01

DOI: 10.5414/cpp47141PMID: 19281722

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.

Barchet TM, Amiji MM.

Expert Opin Drug Deliv · 2009-03-01

DOI: 10.1517/17425240902758188PMID: 19290842

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

22.626 articles found

Voice and choral singing treatment: a new approach for speech and voice disorders in Parkinson's disease.

Electroconvulsive therapy in neuroacanthocytosis or McLeod syndrome.

Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease.

Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.

Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.

Levodopa use and sleep in patients with dementia with Lewy bodies.

Deep brain stimulation versus best medical therapy for advanced Parkinson's disease.

The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease.

Rotigotine transdermal delivery for the treatment of Parkinson's disease.

[Treatment of degenerative dementia disorders--who should be treated?].

Pharmacotherapy guidelines for the aged by family doctors for the use of family doctors: part C--Special pharmacology.

Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.

Filters